Compare PLX & SCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PLX | SCM |
|---|---|---|
| Founded | 1993 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 207.1M | 211.0M |
| IPO Year | 1996 | 2012 |
| Metric | PLX | SCM |
|---|---|---|
| Price | $2.90 | $6.16 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 2 | 5 |
| Target Price | ★ $12.00 | $9.63 |
| AVG Volume (30 Days) | ★ 990.1K | 196.6K |
| Earning Date | 11-10-2026 | 11-09-2026 |
| Dividend Yield | N/A | ★ 15.92% |
| EPS Growth | N/A | ★ N/A |
| EPS | 0.31 | ★ 0.40 |
| Revenue | ★ $52,744,000.00 | N/A |
| Revenue This Year | $64.22 | N/A |
| Revenue Next Year | N/A | $4.20 |
| P/E Ratio | ★ $9.85 | $15.70 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.65 | $6.27 |
| 52 Week High | $3.19 | $13.55 |
| Indicator | PLX | SCM |
|---|---|---|
| Relative Strength Index (RSI) | 56.51 | 26.48 |
| Support Level | $2.08 | N/A |
| Resistance Level | $3.19 | $8.81 |
| Average True Range (ATR) | 0.20 | 0.28 |
| MACD | 0.03 | -0.06 |
| Stochastic Oscillator | 71.74 | 2.27 |
Protalix BioTherapeutics Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, production, and commercialization of therapeutics for rare diseases with important unmet needs. ProCellEx, a proprietary plant cell-based protein expression system, represents a new method for developing recombinant proteins in an industrial-scale manner. corporate includes the development of treatments for rare and orphan diseases. The Company operates as a single operating segment in Israel.
Stellus Capital Investment Corp is a closed-end, non-diversified management investment company. Its objective is to maximize the total return to its stockholders in the form of current income and capital appreciation. It invests in private middle-market companies through first lien, second lien, and unsecured debt financing, often with a corresponding equity investment. The company invests in various sectors, such as business services, energy, general industrial, government services, healthcare, software, and specialty finance. The business activity of the firm functions throughout the United States, and it generates revenue in the form of interest income on debt investments, capital gains, and distributions.